ITRM Live signaler | Maksimer profitt med Getagraph.com

KJøP 116336 min ago

@ $1.650

Utstedt: 7 feb 2024 @ 22:00

Avkastning: 1.21%

Forrige signal: feb 7 - 19:28

Forrige signal: Selg

Avkastning: -3.79 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States...

Stats
Dagens volum	106 263
Gjennomsnittsvolum	615 587
Markedsverdi	27.43M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $-0.570 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.560
ATR14	$0.0110 (0.66%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-22	Dunne Michael W.	Buy	25 000	Ordinary Shares
2023-12-18	Dunne Michael W.	Buy	10 000	Ordinary Shares
2023-12-01	Puttagunta Sailaja	Sell	8 333	Restricted Share Units
2023-12-01	Puttagunta Sailaja	Buy	8 333	Ordinary Shares
2023-12-01	Puttagunta Sailaja	Sell	2 933	Ordinary Shares

INSIDER POWER
76.55
Last 98 transactions
Buy: 8 259 885 \| Sell: 825 272

Volum Korrelasjon

Lang: 0.10 (neutral)

Kort: 0.06 (neutral)

Signal:(49.751) Neutral

Iterum Therapeutics PLC Korrelasjon

10 Mest positive korrelasjoner
RMRM	0.924
TLGT	0.921
NEPT	0.915
SVAC	0.906
PAIC	0.9
WTER	0.9
LPTX	0.885
NXTC	0.866
PSTV	0.866
INVE	0.863

10 Mest negative korrelasjoner
AMRB	-0.953
MMAC	-0.928
NETE	-0.918
BILI	-0.869
BSMS	-0.867
BOCH	-0.864
BSMR	-0.862
BSMT	-0.858
BNIXU	-0.858
BSMU	-0.854

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Iterum Therapeutics PLC Korrelasjon - Valuta/Råvare

-0.81
( strong negative )

-0.57
( weak negative )

0.00
( neutral )

-0.48
( neutral )

0.43
( neutral )

0.50
( neutral )

Iterum Therapeutics PLC Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1.75M (0.00 %)
EPS:	$-2.96

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1.75M (0.00 %)
EPS:	$-2.96

FY	2022
Omsetning:	$0
Bruttogevinst:	$-1.80M (0.00 %)
EPS:	$-3.63

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-57.20

Financial Reports:

No articles found.

Iterum Therapeutics PLC

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.